Elizabeth Ingram
Vorstandsvorsitzender bei Cipla Therapeutics, Inc.
Profil
Elizabeth G.
Ingram is currently the President & Chief Executive Officer at Cipla Therapeutics, Inc. She previously served as an Independent Director at Avenue Therapeutics, Inc. from 2019 to 2022.
Prior to that, she was the Vice President-Market Access Strategy at Bristol Myers Squibb Co. from 2012 to 2014.
Elizabeth also held the position of Chief Marketing Officer at MannKind Corp.
in 2018 and was the Senior Vice President-Managed Market at DexCom, Inc. in 2017.
She completed her undergraduate degree at East Carolina University and her graduate degree at the University of South Carolina.
Aktive Positionen von Elizabeth Ingram
| Unternehmen | Position | Beginn |
|---|---|---|
| Cipla Therapeutics, Inc. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Elizabeth Ingram
| Unternehmen | Position | Ende |
|---|---|---|
| AVENUE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 31.10.2022 |
| MANNKIND CORPORATION | Vertrieb & Marketing | 01.06.2019 |
| DEXCOM, INC. | Corporate Officer/Principal | 01.12.2017 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.01.2014 |
Ausbildung von Elizabeth Ingram
| East Carolina University | Undergraduate Degree |
| University of South Carolina | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| MANNKIND CORPORATION | Health Technology |
| DEXCOM, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AVENUE THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
| Cipla Therapeutics, Inc. |
